Spyros Kitsiou is awarded a five-year $3.5 million R01 grant from the National Heart, Lung, and Blood Institute

Spyros Kitsiou (PI) and his research team have been awarded a five-year $3.5 million R01 grant by the National Institutes of Health/National Heart, Lung, and Blood Institute. The project is titled “iCardia4HF: A multicomponent mHealth app and tailored text messaging intervention to promote self-care adherence and improve outcomes in patients with chronic heart failure.” In this project, Dr. Kitsiou will lead a fully powered 2×2 factorial randomized controlled trial to investigate the independent and combined efficacies of a patient-centered heart failure self-care intervention (iCardia4HF) that combines the use of  multiple commercially available mobile health apps and connected health devices (MyApps) with individually tailored text messages (Text4HF) targeting modifiable behavioral factors associated with HF self-care nonadherence. This Phase II trial will provide important new knowledge that will critically shape our understanding about the potential of commercially available mobile health technologies to improve self-care and reduce hospital readmissions and deaths in patients with chronic heart failure.